Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 3/2009

01-07-2009 | Original Paper

Cost of skin cancer in England

Authors: S. Morris, B. Cox, N. Bosanquet

Published in: The European Journal of Health Economics | Issue 3/2009

Login to get access

Abstract

This paper estimates the financial cost of skin cancer in England. National Health Service (NHS) costs were calculated by combining published data on health service use by patients with skin cancer with published data on the unit cost of services. Indirect costs arising from individuals’ inability to function in their usual role as a result of skin cancer were estimated from incapacity benefit claims and numbers of registered deaths due to skin cancer. The total costs of skin cancer were around £240 million. Costs to the NHS represented 42% of the total.
Literature
1.
Office for National Statistics: Cancer statistics: registrations, series MB1 No. 32. Office for National Statistics, London
2.
3.
Welsh Cancer Intelligence and Surveillance Unit: Cancer incidence 2002 report. Welsh Cancer Intelligence and Surveillance Unit (2004)
4.
5.
Office for National Statistics: Mortality statistics: cause, series DH2 no. 29. Office for National Statistics, London
6.
Quinn, M., Babb, P., Brock, A., et al.: Cancer trends in England and Wales, 1950–1999. The Stationery Office, London (2001)
7.
8.
9.
Housman, T.S., Feldman, S.R., Williford, P.M., et al.: Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol. 48(3), 425–429 (2003)CrossRef
10.
Chen, J.G., Fleischer, A.B., Smith, E.D., et al.: Cost of nonmelanoma skin cancer treatment in the United States. Dermatol. Surg. 27, 1035–1038 (2001)CrossRef
11.
National Institute for Clinical Excellence: Guide to the methods of technology appraisal (reference N0515). National Institute for Clinical Excellence, London (2004)
12.
Office for Population Censuses and Surveys: Morbidity statistics from general practice: fourth national study 1991–1992, series MB5 no. 3. HMSO, London (1995)
13.
Cancer Research UKL: Cancer stats incidence—UK. Cancer Research, UK (2004)
14.
Stefoski Mikeljevic, J., Johnston, C., Adamson, P.J., Wright, A., Bishop, J., Newton, A., Batman, P., Neal, R.D., Forman, D.: How complete has skin cancer registration been in the UK? A study from Yorkshire. Eur. J. Cancer Prev. 12(2), 125–133 (2004)CrossRef
15.
Netten, A., Curtis, L.: Unit costs of health and social care 2003. Personal social services research unit. University of Kent, Canterbury (2003)
16.
Department of Health: Hospital episodes statistics, England: financial year 2002–2003. Department of Health, London (2003)
17.
Department of Health: NHS reference costs 2002. Department of Health, London (2003)
18.
Kernick, D.P., Reinhold, D.M., Netten, A.: What does it cost the patient to see the doctor? Br. J. Gen. Pract. 50, 401–403 (2000)
19.
Office for National Statistics: Annual abstract of statistics No. 140. The Stationery Office, London (2004)
20.
Liu, J.L., Maniadakis, N., Gray, A., Rayner, M.: The economic burden of coronary heart disease in the UK. Heart 88, 597–603 (2002)CrossRef
21.
Bosanquet, N., Sikora, K.: The economics of cancer care in the UK. Lancet. Oncol. 5, 568–574 (2004)CrossRef
22.
Carter, R., Marks, R., Hill, D.: Could a national skin cancer primary prevention campaign in Australia be worthwhile? An economic perspective. Health. Promot. Int. 14, 73–82 (1999)CrossRef
23.
Kyle, J.W., Hammitt, J.K., Lim, H.W., et al.: Economic evaluation of the US Environmental Protection Agency’s SunWise program: sun protection education for young children. Pediatrics 121(5), e1074–e1084 (2008)CrossRef
Metadata
Title
Cost of skin cancer in England
Authors
S. Morris
B. Cox
N. Bosanquet
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
The European Journal of Health Economics / Issue 3/2009
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-008-0127-0

Other articles of this Issue 3/2009

The European Journal of Health Economics 3/2009 Go to the issue

Original Paper

Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study

Original Paper

The economics of cochlear implant management in France: a multicentre analysis

Original Paper

Material versus social deprivation and health: a case study of an urban area

Original Paper

Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach

Original Paper

The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals

Editorial

Why the econometrician is in good spirits: a workshop through the looking glass